XML 74 R60.htm IDEA: XBRL DOCUMENT v3.24.1
SHAREHOLDERS’ EQUITY (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
Aug. 01, 2023
Aug. 01, 2023
Aug. 31, 2023
Feb. 28, 2023
Jul. 31, 2022
Apr. 30, 2022
Dec. 31, 2023
Dec. 31, 2022
Apr. 04, 2022
Dec. 31, 2021
Apr. 30, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Cash consideration $ 16,792,037                    
Payment in cash             $ 3,089,645 $ 11,125,872      
Options to acquire shares           144,191        
Weighted exercise price           $ 10.71          
Warrants to purchase shares           4,424          
Exercise price           $ 7.32          
Expiration date           Apr. 22, 2031          
Payments to contingent consideration $ 893,000                    
Cash     $ 693,000                
Cash consideration         $ 10,000,000.0            
Number of shares         486,145            
Earnout payment     $ 693,000                
Number of shares issued, value             $ 911,371        
Stock granted and issued             100,829        
Restricted stock award, gross             $ 4,045,377        
Share-based compensation             3,442,722 $ 2,702,633      
Accrued liability                   $ 1,038,183  
Unrecognized share-based compensation expense             $ 2,877,664        
Unrecognized share-based compensation expense period for recognition             1 month 6 days        
Cash Closing Consideration [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Payments to acquire assets   $ 15,250,000                  
Stock issued during period shares issued for services   73,809                  
Purchase Agreement [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Issuance of common stock in equity offering, shares         94,798            
Payments to acquire assets         $ 7,600,000            
Cash         $ 1,600,000            
Issuance of common stock for purchase of assets         291,686            
Net proceeds         $ 1,950,000            
Common Stock [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Issuance of common stock in equity offering, shares             26,143        
Issuance of common stock for acquisitions, shares             73,809 457,424      
Payment in cash             $ 74 $ 457      
Warrants to purchase shares           12,301          
Exercise price           $ 12.05          
Expiration date           Aug. 10, 2030          
Number of shares issued, value             $ 26        
Common Stock [Member] | Sales Agreement [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Issuance of common stock in equity offering, shares             26,143        
Number of shares issued, value             $ 1,100,000        
Net proceeds             $ 900,000        
Precision Healing [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Payment in cash           $ 600,000          
Share price           $ 27.13         $ 27.13
Cantor Fitzgerald and Co [Member] | Sales Agreement [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Percentage of commissions payable to sales agent       3.00%              
Cantor Fitzgerald and Co [Member] | Sales Agreement [Member] | Maximum [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Sale of stock, consideration received on transaction       $ 75,000,000              
Accredited Investors [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Issuance of common stock for acquisitions, shares           165,738          
Nonaccredited Investors [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Share price                 $ 30.75    
Precision Healing Inc [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Cash consideration           $ 125,966          
Payments to contingent consideration           $ 10,000,000.0          
Restated 2014 Omnibus Long Term Incentive Plan [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Number of shares available for issuance             1,419,503        
Restated 2014 Omnibus Long Term Incentive Plan [Member] | Directors Officers Employees [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Issuance of common stock in equity offering, shares             580,497